Symbiorix financials
A multi-period view of the public annual-account figures reported for Symbiorix, with comparable measures and links to available source documents.
Company overviewRegistry number
0811329675
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Symbiorix
2025 versus 2024
- Operating line
- €962,685
- EBITDA
- €512,660
- Total assets
- €1,290,228
- Equity
- €706,744
+2.6%
+15.8%
-3.1%
0%
EBITDA margin +53.3% · Equity ratio +54.8%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €962,685 | €512,660 | €1,290,228 | €706,744 | - |
| 202431 Dec 2024 | €938,476 | €442,724 | €1,330,993 | €706,744 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.